GLP-1 drugs linked to reduced risk of epilepsy
A retrospective analysis of data from adults treated for type-2 diabetes indicates that glucose-lowering GLP-1 drugs could be linked to a lower risk of epilepsy. The findings appeared… read more.
A retrospective analysis of data from adults treated for type-2 diabetes indicates that glucose-lowering GLP-1 drugs could be linked to a lower risk of epilepsy. The findings appeared… read more.
Treating malignant melanoma with lower doses of approved immunotherapy appears to result in improved results, while also reducing side effects. Investigators from the Karolinska Institutet in Stockholm, Sweden… read more.
Researchers report that an analysis of data from outpatient facilities in the New York State region revealed that 20-24% of breast cancers breast cancers diagnosed in an 11-year… read more.
Orforglipron , an investigative and oral GLP-1 drug, appears to enable adults with obesity and Type 2 diabetes to achieve significantly more weight loss and improvement in blood… read more.
Patients with colon cancer who are using glucagon-like peptide-1 (GLP-1) receptor agonists for blood sugar regulation and/or weight control appear to have achieved a significantly lower risk of… read more.
Obese or overweight non-diabetic adults with atrial fibrillation (Afib) who take the diabetes medication metformin after a catheter ablation are more likely to remain free of AFib for… read more.
Adults treated for atrial fibrillation (AFib/AF) who consume a daily cup of coffee are 39% less likely to have an irregular heart rhythm episode compared to those who… read more.
Researchers report that people drinking three or more alcoholic drinks per day are at a significantly greater risk of intracerebral hemorrhage (a type of stroke caused by bleeding… read more.
Women treated with antibiotics within 24 hours of having an obstetric tear during childbirth have achieved a lower risk of larger/clinically relevant wound complications than women who do… read more.
Researchers report success in using pazopanib to treat young patients diagnosed with deadly Ewing’s sarcoma. They published their findings on Oct. 23, 2025 in Frontiers in Oncology As… read more.
People with gum disease plus cavities have a significantly increased risk of suffering an ischemic stroke compared to those with a healthy mouth, researchers report. The findings were… read more.
Researchers report that overall survival is significantly longer among prostate cancer patients at high-risk of biochemical recurrence who are treated with combination enzalutamide and leuprolide rather than with… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.